Arsenic Sulfide Nanoformulation Induces Megakaryocytic Differentiation through Histone Deacetylase Inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Arsenic Sulfide Nanoformulation Induces Megakaryocytic Differentiation through Histone Deacetylase Inhibition

Published:2019-11-21 Issue:5 Volume:3 Page:1900151
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Adv. Therap.

Author:

Jia Mengfan¹,Wang Tao¹,Xu Shilin¹,Liu Jian¹,Wen Tao¹,Meng Jie¹,Xu Haiyan¹^ORCID

Affiliation:

1. Institute of Basic Medical SciencesChinese Academy of Medical Sciences & Peking Union Medical College Beijing 100005 China

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry, medical,Genetics(clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.201900151

Reference30 articles.

1. BCR–ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor

2. The Biology of Chronic Myeloid Leukemia

3. Imatinib Mesylate — A New Oral Targeted Therapy

4. Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry

5. HDACs and HDAC Inhibitors in Cancer Development and Therapy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. As4S4 nanoparticles promote effective terminal erythropoiesis in bone marrow mononuclear cells from patients with myelodysplastic syndromes;Nano Today;2023-10

2. Functional Nanorealgar Quantum Dots with Aggregation-Induced Emission Enhancement for Tumor Neovascular-Targeted Theranostics;Journal of Nanomaterials;2023-01-17

3. Hydrophilic Realgar Nanocrystals Prolong the Survival of Refractory Acute Myeloid Leukemia Mice Through Inducing Multi-Lineage Differentiation and Apoptosis;International Journal of Nanomedicine;2022-05

4. Fluorescent Realgar Nanoclusters for Nuclear Targeting-Triggered Tumor Theranostics;ACS Applied Nano Materials;2022-04-26

5. Multi-faced roles of reactive oxygen species in anti-tumor T cell immune responses and combination immunotherapy;Exploration of Medicine;2022-02-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3